4basebio PLC header image

4basebio PLC

88Q

Equity

ISIN GB00BMCLYF79 / Valor 112829117

Xetra (2026-10-06)
EUR 6.63%

4basebio PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

4basebio PLC, formerly known as 4basebio SLU, is a company that specializes in the development and sale of DNA products. The company holds intellectual property related to DNA technologies, with a focus on DNA amplification and sequencing. The Madrid-based team has expertise in synthetic DNA development, utilizing technologies like TruePrime© for efficient and cost-effective production of high-quality DNA. Professor Luis Blanco, a renowned researcher in DNA polymerases, played a key role in the company's origins and continues to contribute to its development agenda. 4basebio PLC is dedicated to advancing its platform development and scaling production to commercial levels, positioning itself as a leader in the DNA products market.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-25.6%1Y
2.08%3Y
%5Y

Performance

39.9%1Y
34.2%3Y
37.8%5Y

Volatility

Market cap

115 M

Market cap (USD)

Daily traded volume (Shares)

8

Daily traded volume (Shares)

1 day high/low

14.2 / 14.2

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

IQVIA Holdings Inc
IQVIA Holdings Inc IQVIA Holdings Inc Valor: 39103858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.30%USD 259.98
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.01%USD 7.31
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 982352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.65%GBP 119.58
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1103058
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%GBP 10.12
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%USD 23.27
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.05%USD 404.27
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.60%GBP 16.20
Indivior PLC
Indivior PLC Indivior PLC Valor: 121550831
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.67%GBP 27.04
Beximco Pharmaceuticals Ltd
Beximco Pharmaceuticals Ltd Beximco Pharmaceuticals Ltd Valor: 2318407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 0.54
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%EUR 70.30